Prévisions du marché des réactifs et équipements de transfection en Asie-Pacifique jusqu’en 2030 – Analyse régionale – par produit (réactifs et instruments), méthode (méthodes virales, méthodes non virales et méthodes hybrides), application (recherche biomédicale, production de protéines et administration thérapeutique) et Utilisateur final (universités et instituts de recherche et sociétés pharmaceutiques et biotechnologiques)
Le fardeau économique croissant du cancer stimule le marché des réactifs et des équipements de transfection en Asie-Pacifique
Selon l\'Organisation mondiale de la santé (OMS) , le cancer est l\'une des principales causes de décès dans le monde et a causé environ 10 millions de décès en 2020. Selon le Centre international de recherche sur le cancer, le fardeau mondial du cancer est susceptible d\'augmenter avec l\'ajout de 30,2 millions de cas supplémentaires d\'ici 2040. Selon l\'Organisation du cancer du sein, environ 5 à 10 % des cas de cancer du sein dans le monde sont héréditaires et sont causés par des gènes anormaux transmis de génération en génération. Selon l\'article « Mode de vie, risque génétique et incidence du cancer », publié dans l\'International Journal of Epidemiology en 2023, près de 33 % des cancers qui surviennent sont héréditaires et le risque de mutations génétiques est élevé dans la maladie. C’est pourquoi les gens optent pour le profilage génétique pour la détection précoce et le traitement personnalisé des cas de cancer héréditaire. BRCA1 et BRCA2 sont parfois appelés gènes suppresseurs de tumeurs. Les personnes qui héritent des variantes nocives de l’un de ces gènes courent un risque plus élevé de plusieurs cancers, notamment le cancer du sein et de l’ovaire, entre autres types. Ces personnes ont également tendance à développer un cancer à un âge plus jeune que les personnes qui ne présentent pas de variations dans lesdits gènes. Les études axées sur le traitement des acides nucléiques par les cellules cancéreuses aideront probablement à comprendre le métabolisme du cancer. L\'ADN est généralement conditionné dans une particule virale ou non virale pour être transféré dans la cellule à transfecter. Le transfert de gènes a été proposé comme nouvelle approche pour améliorer l\'efficacité des médicaments antitumoraux dans le traitement des cancers incurables ou métastatiques. Il a été rapporté que l’association de thérapie génique et de médicaments (thérapie similaire) renforce les effets antiprolifératifs des traitements classiques dans les cancers du poumon, colorectal, pancréatique, de la vessie et du sein, entre autres. Ainsi, le fardeau économique croissant du cancer renforce le marché des réactifs et des équipements de transfection en Asie-Pacifique.
Aperçu du marché des réactifs et équipements de transfection en Asie-Pacifique
La région Asie-Pacifique est classée en Chine, Japon, Inde, Corée du Sud, Australie et reste de l\'Asie-Pacifique. La Chine détient la plus grande part de marché en 2022. Des pays de la région Asie-Pacifique comme la Chine, l’Inde, Singapour et d’autres encore disposent d’un système de santé bien établi ainsi que d’industries pharmaceutiques et médicales à croissance rapide. Ces pays disposent de nombreux établissements de santé offrant des services de traitement et de soins aux patients atteints de cancer. Selon une étude du NIH, les admissions annuelles de patients dans les hôpitaux de cancérologie en Chine sont passées de 1,10 million à 3,24 millions entre 2010 et 2020. Selon une étude publiée en 2023 dans le Journal of the American Medical Association, la prévalence de l\'insuffisance rénale chronique (IRC) chez les personnes âgées de 18 ans ou plus en Chine continentale est enregistrée à 8,2 %. De plus, les dernières données du Centre international de recherche sur le cancer (CIRC) indiquent que le taux standardisé selon l\'âge (ASR) estimé pour le cancer de l\'estomac en Chine est de 21 pour 100 000, et le taux brut est de 33,06 ; pour le cancer du pancréas, l\'ASR est de 5 pour 100 000 avec un taux brut de 8,6. Selon la même source, le nombre estimé de nouveaux cas de cancer de l\'estomac et de cancer du pancréas chez les personnes âgées de 0 à 74 ans en 2020 (pour les deux sexes) était respectivement de 478 508 et 124 994. Ainsi, le lourd fardeau des maladies chroniques propulse la demande de CGT en Chine, alimentant à son tour la croissance du marché des réactifs et des équipements de transfection.
Revenus et prévisions du marché des réactifs et équipements de transfection en Asie-Pacifique jusqu\'en 2030 (millions de dollars américains)
Segmentation du marché des réactifs et équipements de transfection en Asie-Pacifique
Réactifs et équipements de transfection en Asie-Pacifique le marché est segmenté en fonction du produit, de la méthode, de l’application, de l’utilisateur final et du pays.
En fonction du produit, le marché des réactifs et équipements de transfection de la région Asie-Pacifique est divisé en réactifs et instruments. Le segment des réactifs détenait une part plus importante en 2022.
En termes de méthode, le marché des réactifs et des équipements de transfection en Asie-Pacifique est segmenté en méthodes virales, méthodes non virales et méthodes hybrides. Le segment des méthodes non virales détenait la plus grande part en 2022. Le segment viral est sous-catégorisé en rétrovirus, adénovirus, virus adéno-associé et virus de l\'herpès. Le segment non viral est divisé en méthode physique/mécanique et méthode chimique. En outre, le segment des méthodes physiques/mécaniques est sous-catégorisé en électroporation, microinjection, méthode biolistique, méthode laser, magnétofection et sonoporation. En outre, le segment des méthodes chimiques est sous-catégorisé en liposomal/à haute teneur en lipides et non liposomal/à haute teneur en lipides.
Par application, le marché des réactifs et équipements de transfection de l\'Asie-Pacifique est segmenté en recherche biomédicale, production de protéines et administration thérapeutique. Le segment de la recherche biomédicale détenait la plus grande part en 2022.
Sur la base de l\'utilisateur final, le marché des réactifs et équipements de transfection de l\'Asie-Pacifique est divisé en universités et instituts de recherche et sociétés pharmaceutiques et biotechnologiques. Le segment des universitaires et des instituts de recherche détenait une part plus importante en 2022.
En fonction des pays, le marché des réactifs et équipements de transfection de la région Asie-Pacifique est classé en Australie, Chine, Inde, Japon, Corée du Sud et reste de l\'Asie. Pacifique. La Chine a dominé le marché des réactifs et équipements de transfection en Asie-Pacifique en 2022.
Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc et Polyplus-Transfection SA font partie des principales sociétés opérant sur le marché des réactifs et des équipements de transfection en Asie-Pacifique.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Asia Pacific Transfection Reagents and Equipment Market Forecast Analysis
6. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Transfection Reagents and Equipment Market -Country Analysis
10.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 China: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.1.2 China: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.1.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.1.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.1.2.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.1.2.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.1.3 China: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.1.4 China: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.2 Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Japan: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Japan: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 India: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 India: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 India: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 India: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 South Korea: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 South Korea: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.5 Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.5.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.5.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.5.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.5.2.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.5.2.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.5.3 Australia: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.5.4 Australia: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.6 Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.6.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.6.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.6.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.6.2.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.6.2.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.6.3 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.6.4 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation
Table 2. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 45. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 46. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 47. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 48. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 49. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 50. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 51. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 52. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 53. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 54. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 55. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 56. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 57. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 58. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 59. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Asia Pacific: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.